SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-060582
Filing Date
2021-12-16
Accepted
2021-12-16 16:30:24
Documents
12
Period of Report
2021-12-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20211214.htm   iXBRL 8-K 41806
  Complete submission text file 0001564590-21-060582.txt   170675

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA abio-20211214.xsd EX-101.SCH 5705
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20211214_lab.xml EX-101.LAB 19339
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20211214_pre.xml EX-101.PRE 11505
5 EXTRACTED XBRL INSTANCE DOCUMENT abio-8k_20211214_htm.xml XML 3519
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 211498136
SIC: 2835 In Vitro & In Vivo Diagnostic Substances